Legacy App users can now access the Health Portal – just reset your password using email as username.

Does Testosterone Raise Cholesterol And Increase Heart Risk?

Does Testosterone Raise Cholesterol And Increase Heart Risk?

Viewing This Video Is A Member Exclusive Feature

But you don’t need membership to get Dr. O’Connor’s insight on this topic, it’s in the summary, key takeaways, and related drugs and conditions below.

Want to watch the full video? Join the Health Portal Today.

Join Now

Timeline

Timestamp
Topic
00:00
Dr. O’Connor addresses elevated cholesterol during testosterone use. He discusses individual variation, LDL, ApoB, Lp(a), and family history as factors needed to interpret cardiovascular risk.
01:30
The discussion expands to blood pressure, blood sugar, inflammation, and plaque characteristics. Dr. O’Connor discusses coronary calcium scoring and emphasizes knowing A1C, blood pressure, and cholesterol numbers through the ABCDs™ framework.
03:01
Dr. O’Connor turns to diet, exercise, smoking, alcohol, and longevity. He mentions cardiovascular medications and supplements while emphasizing that supplements complement rather than replace healthy behavior and appropriate medical treatment.

Video Summary

A man reports slightly elevated cholesterol while using testosterone and asks whether this is normal. Dr. O’Connor describes testosterone’s overall cholesterol effects as relatively neutral in the research he references, while acknowledging that individual responses and dose can affect LDL cholesterol and ApoB.

He emphasizes looking beyond a single cholesterol result. Lipoprotein(a), or Lp(a), is discussed as a largely inherited cardiovascular risk factor, and he highlights testing and family history of premature heart disease as important parts of the assessment.

The discussion broadens to blood sugar, blood pressure, inflammation, and atherosclerotic plaque. Dr. O’Connor contrasts unstable plaque with calcified plaque and recommends considering coronary calcium scoring within the broader cardiovascular picture. He does not have the questioner’s age or complete medical history.

Using the ABCDs™ framework, he emphasizes knowing A1C, blood pressure, and cholesterol numbers. Diet, exercise, smoking avoidance, and caution with alcohol are discussed as foundations of long-term cardiovascular care.

He closes by mentioning several medications and supplements in the context of cardiovascular health and longevity. These are not presented as an individualized regimen for the questioner. He emphasizes that supplements should complement healthy behavior and appropriate medication rather than replace them.

Drug Callouts

Drug
Description
Testosterone
Testosterone is an androgen hormone used medically to replace deficient testosterone in men with certain forms of hypogonadism. In this discussion, Dr. O’Connor addresses a cholesterol increase during testosterone use and emphasizes that dose, individual response, and overall cardiovascular risk affect its interpretation.
Metformin
Metformin is a medication for type 2 diabetes that reduces glucose production by the liver and improves the body's response to insulin. Dr. O’Connor places it within the broader discussion of metabolic health and longevity, reinforcing that cardiovascular care extends beyond cholesterol alone.
Jardiance
Jardiance, or empagliflozin, is an SGLT2 inhibitor that increases urinary glucose excretion and is used for type 2 diabetes, heart failure, and chronic kidney disease in appropriate patients. Dr. O’Connor includes it among medication options in his broader cardiovascular discussion, connecting metabolic, heart, and kidney health rather than treating elevated cholesterol as an isolated issue.
Farxiga
Farxiga, or dapagliflozin, is an SGLT2 inhibitor used to treat type 2 diabetes and certain heart failure and chronic kidney disease conditions. Dr. O’Connor includes it in the wider cardiovascular medication landscape rather than presenting it as a cholesterol-lowering treatment for the questioner.
Repatha
Repatha, or evolocumab, is an injectable PCSK9 inhibitor that helps the liver remove LDL cholesterol from the blood and reduces cardiovascular events in appropriate patients. Dr. O’Connor includes it alongside statins as a medication option within a broader strategy for managing cholesterol-related cardiovascular risk.
Statins
Statins are medications that reduce cholesterol production in the liver, lower LDL cholesterol, and help prevent heart attacks and strokes in appropriate patients. Dr. O’Connor presents them as part of cardiovascular risk management while emphasizing that supplements should complement rather than replace appropriate medication.

Condition Callouts

Condition
Description
Elevated Cholesterol
Elevated cholesterol means blood cholesterol levels are above a healthy range, with excess LDL cholesterol contributing to plaque buildup in arteries. For men using testosterone or anabolic steroids, Dr. O’Connor emphasizes evaluating the lipid pattern and broader cardiovascular risks rather than dismissing an increase as normal during androgen use.
Atherosclerosis
Atherosclerosis is the buildup of plaque containing cholesterol, fat, calcium, and other substances within artery walls, which can restrict blood flow or lead to cardiovascular events. For men using testosterone or anabolic steroids, Dr. O’Connor connects family history, lipid testing, and coronary calcium scoring to understanding underlying arterial disease.
Hypertension
Hypertension is persistently elevated pressure within the arteries that can damage blood vessels and increase the risk of heart disease, stroke, and kidney disease. For men using testosterone or anabolic steroids, Dr. O’Connor places blood pressure control alongside cholesterol and blood sugar management as a foundation of cardiovascular care.

Key Takeaways

  • Elevated LDL cholesterol contributes to arterial plaque buildup, so a cholesterol increase during testosterone use should be assessed rather than assumed to be harmless.
  • ApoB reflects the number of plaque-forming lipoprotein particles in the blood and can reveal additional risk when LDL cholesterol alone appears reassuring.
  • Lipoprotein(a) is largely inherited and can increase heart disease and stroke risk independently of an otherwise reassuring cholesterol profile.
  • Coronary calcium scoring measures calcified plaque in the heart's arteries and can help refine cardiovascular risk assessment when interpreted alongside other risk factors.
  • Managing cholesterol together with blood pressure, blood sugar, physical activity, and smoking exposure addresses multiple contributors to atherosclerosis.
  • Supplements should complement diet, exercise, and appropriate prescribed treatment rather than replace medications needed to manage cardiovascular risk.